Publications - Visterra

Featured publications

Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow

July 28, 2025 | Journal of the American Society for Mass Spectrometry

Arnik Shah, et al.

Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow

Arnik Shah, Parth Shah, Alex Johnson, Jean Bender, Dmitry Gumerov, Jingwen Ding, Scott Mack, Matthew D. Stone, Maggie A. Ostrowski

>READ

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

November 2, 2023 | The New England Journal of Medicine

Mohit Mathur, et al.

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

Mohit Mathur, Jonathan Barratt, Bobby Chacko, Tak Mao Chan, Laura Kooienga, Kook-Hwan Oh, Manisha Sahay, Yusuke Suzuki, Muh Geot Wong, Jill Yarbrough, Jing Xia, Brian J G Pereira

>READ

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

April 5, 2023 | Frontiers in Molecular Biosciences

Steven Pregizer, et al.

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

Steven Pregizer, Thom Vreven, Mohit Mathur, Luke Robinson

>READ

The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.

March 25, 2016 | Antimicrobial Agents and Chemotherapy

Tatiana Baranovich et al.

The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.

Tatiana Baranovich, Jeremy C Jones, Marion Russier, Peter Vogel, Kristy J Szretter, Susan E Sloan, Patrick Seiler, Jose M Trevejo, Richard J Webby, Elena A Govorkova

>READ

Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks

March 5, 2016 | EBioMedicine

Andrew M. Wollacott et al.

Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks

Andrew M. Wollacott, Maciej F. Boni, Kristy J. Szretter, Susan E. Sloan, Mona Yousofshahi, Karthik Viswanathan, Sylvain Bedard, Catherine A. Hay, Patrick F. Smith, Zachary Shriver, and Jose M. Trevejo

>READ

A broadly neutralizing human monoclonal antibody is effective against H7N9.

August 7, 2015 | PNAS

Kannan Tharakaraman et al.

A broadly neutralizing human monoclonal antibody is effective against H7N9.

Kannan Tharakaraman, Vidya Subramanian, Karthik Viswanathan, Susan Sloan, Hui-Ling Yen, Dale L. Barnard, Y. H. Connie Leung, Kristy J. Szretter, Tyree J. Koch, James C. Delaney, Gregory J. Babcock, Gerald N. Wogan, Ram Sasisekharan, and Zachary Shriver

>READ

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.

July 30, 2015 | Cell

Luke N. Robinson et al.

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.

Luke N. Robinson, Kannan Tharakaraman, Kirk J. Rowley, Vivian V. Costa, Kuan Rong Chan, Yee Hwa Wong, Li Ching Ong, Hwee Cheng Tan, Tyree Koch, David Cain, Rama Kirloskar, Karthik Viswanathan, Chong Wai Liew, Hamid Tissire, Boopathy Ramakrishnan, James R. Myette, Gregory J. Babcock, V. Sasisekharan, Sylvie Alonso, Jianzhu Chen, Julien Lescar, Zachary Shriver, Eng Eong Ooi, Ram Sasisekharan

>READ

Antibody-Based Strategies to Prevent and Treat Influenza.

July 13, 2015 | Frontiers in Immunology

Zachary Shriver et al.

Antibody-Based Strategies to Prevent and Treat Influenza.

Zachary Shriver, Jose M Trevejo, Ram Sasisekharan

>READ

Amino acid interaction networks provide a new lens for therapeutic antibody discovery and anti-viral drug optimization.

April 11, 2015 | Current Opinion in Virology

Karthik Viswanathan et al.

Amino acid interaction networks provide a new lens for therapeutic antibody discovery and anti-viral drug optimization.

Karthik Viswanathan, Zachary Shriver, Gregory J Babcock

>READ

Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity.

June 20, 2013 | Cell

Kannan Tharakaraman et al.

Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity.

Kannan Tharakaraman, Rahul Raman, Karthik Viswanathan, Nathan W Stebbins, Akila Jayaraman, Arvind Krishnan, V Sasisekharan, Ram Sasisekharan

>READ

Glycan receptor binding of the influenza A virus H7N9 hemagglutinin.

June 6, 2013 | Cell

Kannan Tharakaraman et al.

Glycan receptor binding of the influenza A virus H7N9 hemagglutinin.

Kannan Tharakaraman, Akila Jayaraman, Rahul Raman, Karthik Viswanathan, Nathan W Stebbins, David Johnson, Zachary Shriver, V Sasisekharan, Ram Sasisekharan

>READ

Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles.

May 22, 2013 | Virus Research

Charlermchai Artpradit et al.

Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles.

Charlermchai Artpradit, Luke N Robinson, Boris K Gavrilov, Troy T Rurak, Mathuros Ruchirawat, Ram Sasisekharan

>READ

Quantitative characterization of glycan-receptor binding of H9N2 influenza A virus hemagglutinin.

April 23, 2013 | PLoS One

Karunya Srinivasan et al.

Quantitative characterization of glycan-receptor binding of H9N2 influenza A virus hemagglutinin.

Karunya Srinivasan, Rahul Raman, Akila Jayaraman, Karthik Viswanathan, Ram Sasisekharan

>READ